Effects of Topoisomerase II Inhibitors on Gene Expression Patterns
Author Information
Author(s): Reymann Susanne, Borlak Jürgen
Primary Institution: Fraunhofer Institute of Toxicology and Experimental Medicine (Fh-ITEM)
Hypothesis
Topoisomerase II inhibition leads to significant co-localization of regulated genes.
Conclusion
Topoisomerase II inhibitors cause significant co-localization of regulated genes due to the inability of the enzyme complexes to religate DNA.
Supporting Evidence
- The study confirmed previous findings of gene co-localization in response to topoisomerase II inhibitors.
- Statistically significant co-localization was observed within 0–100 kbp windows.
- Different topoisomerase II inhibitors showed similar patterns of gene regulation.
- Overexpression of c-myc did not inhibit topoisomerase II activity, leading to different gene expression patterns.
Takeaway
When certain drugs are used, genes that are turned on or off tend to be found close together in the DNA, which helps scientists understand how these drugs work.
Methodology
Microarray data from treated human hepatocytes and mouse lymphoma cells were analyzed for gene expression patterns.
Potential Biases
Potential bias in gene selection and treatment effects may influence results.
Limitations
The study primarily focuses on specific topoisomerase II inhibitors and may not generalize to all conditions.
Participant Demographics
Human hepatocytes and mouse lymphoma cells were used in the study.
Statistical Information
P-Value
0.00000857
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website